Identifying pathways by which genetic Alzheimer's disease (AD) risk factors exert neurocognitive effects in young adults are essential for the effort to develop early interventions to forestall or prevent AD onset. Here, in a brain-imaging cohort of 59 young adults, we investigated effects of a variant within the clusterin (CLU) gene on working memory function and gray matter volume in cortical areas that support working memory. In addition, we investigated the extent to which effects of CLU genotype on working memory were independent of variation in the strongest AD risk factor gene apolipoprotein E (APOE). CLU is among the strongest genetic AD risk factors and, though it appears to share AD pathogenesis-related features with, APOE, it has been far less well studied. CLU genotype was associated with working memory performance in our study cohort. Notably, we found that variation in gray matter volume in a parietal region, previously implicated in maintenance of information for working memory, mediated the effect of CLU on working memory performance. APOE genotype did not affect working memory within our sample, and did not interact with CLU genotype. To our knowledge, this work represents the first evidence of a behavioral effect of CLU genotype in young people. In addition, this work identifies the first geneÀ brain À cognition mediation effect pathway for the transmission of the effect of an AD risk factor. Relative to conventional pairwise associations in cognitive neurogenetic research, geneÀ brainÀ cognition mediation modeling provides a more integrated understanding of how genetic effects transmit from gene to brain to cognitive function.
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Introduction
Alzheimer's disease (AD) is the most common form of dementia, affecting about 11% of people over 65 years old and 32% of people over 85, creating a pressing public health concern (Thies & Bleiler, 2013) . AD etiology has a strong genetic component, with heritability between 60% and 80% (Gatz et al., 2006) . The earliest and most consistent genetic finding in AD genetics is the association between the ε4 variant of the apolipoprotein E (APOE) gene and risk for AD (Corder et al., 1993) . However, genome-wide association studies (GWAS) have highlighted other risk genes. In 2009, two independent GWAS reported AD risk associated with a single nucleotide polymorphism (SNP), rs11136000, in the clusterin (CLU) gene, also known as apolipoprotein J (APOJ), which encodes a protein similar to APOE (Harold et al., 2009; Lambert et al., 2009 ). The CLU-T allele is protective against AD (0.86 odds ratio), whereas the CLU-C allele (defined here as "normal risk") is associated with relatively greater risk of AD compared to the T allele. CLU has been implicated in AD risk across multiple studies (Carrasquillo et al. 2010; Corneveaux et al., 2010; Jun et al., 2010; Kamboh et al., 2012; Seshadri et al., 2010) , and meta-analyses demonstrate it to be the third most significantly associated genetic risk factor associated with AD (Alzgene: http://www.alzgene.org; Bertram & Tanzi, 2010) .
Given the recent association of CLU with Alzheimer's disease, it is important to investigate whether differences in CLU rs11136000 risk status are associated with differences in brain structure or cognitive function. Key questions remain about the effects of CLU in young healthy people, which may support the development of early biomarkers that present before the onset of AD. Memoryrelated neurocognitive variables that are compromised in AD pathogenesis are strong candidates for investigation, including working memory, which was the focus of the present investigation.
Effects of CLU rs11136000 on cognition and brain functioning in elderly populations have been examined by some recent studies. In a large sample of individuals in their nineties, homozygous C allele carriers had worse cognitive functioning as measured by a composite score consisting of verbal fluency, forward and backward digit span, and immediate and delayed recall (Mengel-From, Christensen, McGue, & Christiansen, 2011 
